Dermatology Skills for Primary Care

Trozak, Daniel J.; Tennenhouse, Dan J.; Russell, John J.

doi:10.1385/1592599060

Cited by 5 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…By assessing the degree of DAT, we graded epidermal atrophy (as manifested by the shiny appearance of the lesion) as mild DAT or DAT 1 to make the assessment simple [15]. The DAT2 and -3 scores depend on the degree of dermal depression.…”

Section: Discussionmentioning

confidence: 99%

Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept study

et al. 2009

View full text Add to dashboard Cite

To complete the LS Cutaneous Assessment Tool (LoSCAT), we developed and evaluated the psychometric properties of the LoSDI and PGA-D in addition to the LS Skin Severity Index (LoSSI). These instruments will facilitate evaluation of LS patients for individual patient management and clinical trials. LoSDI and PGA-D demonstrated excellent reliability and high validity. LoSCAT provides an improved understanding of LS natural history. Further study in a larger group of patients is needed to confirm these preliminary findings.

show abstract

Section: Discussionmentioning

confidence: 99%

Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept study

et al. 2009

View full text Add to dashboard Cite

show abstract

“…6 Keratoacanthomas are rapidly growing, dome-shaped nodules with a central grey-yellow coloured keratotic plug which often undergo spontaneous resolution over 2 to 6 months, leaving a residual scar. 7 Other lesions commonly mistaken for keratoacanthoma include SCC, BCC, pilomatricoma, and fibroepethelial polyps. 8 The presence of inflammation and tenderness surrounding SCC and malignant melanoma have been described in an earlier article.…”

Section: Resultsmentioning

confidence: 99%

Nodular Melanoma Mimicking Keratoacanthoma : Lessons to Learn = ورم ميلانيني عقدي يحاكي ورم شائكي متقرن : دروس للتعل

Muthupalaniappen¹,

Das²,

Nor³

et al. 2012

SQUMJ

View full text Add to dashboard Cite

abstract:A 67-year-old man of Chinese descent presented with a painless nodular lesion that had been present on his right forearm for the previous 3 months. A single, well-defined, dome-shaped, firm nodule with a central keratin plug surrounded by erythema was noted. Keratoacanthoma with secondary bacterial infection was suspected and the patient underwent an excision biopsy. Biopsy of the nodule and immunohistochemical staining supported a diagnosis of nodular malignant melanoma. It should be noted both that nodular malignant melanoma may present with a wide variety of clinical appearances, and that the lack of melanin pigment in nodular malignant melanoma may hinder the diagnosis of this aggressive tumour.

show abstract

“…21 Although a review published on the management of cutaneous erythrasma describes the effect of clotrimazole on erythrasma as "poor and inconclusive", 8 many other studies support the point that clotrimazole can be considered as a drug of choice for treating erythrasma. [22][23][24][25] On the other hand, sertaconazole has been used less as a drug of choice for treatment of erythrasma, but potent pieces of evidence support this opinion. For example, a study conducted on dermatitis features and treatments suggests that applying sertaconazole on the inflamed area twice a day for 14 days causes more than 50% decrease in clinical signs.…”

Section: Discussionmentioning

confidence: 99%

Treatment of erythrasma: A double-blinded randomized controlled trial on the clinical application of clotrimazole and sertaconazole

et al. 2020

View full text Add to dashboard Cite

Introduction Skin diseases contain a broad spectrum of disorders, varying from pyogenic skin infections to malignant melanomas. 1,2 The lack of hygiene, along with other predisposing factors like genetics and climatic characteristics, can intensify the spread of skin disorders, especially in public environments like schools and prisons. 3,4 For example, opportunist fungi such as Malassezia, Candida, Trichosporon and Aspergillus can result in skin and superficial fungal infections. The prevalence and the manifestations of these diseases are dependent on environmental conditions, patients' lifestyle and socioeconomic status of the community. 5 Hence, they can be considered limited and preventable disorders. 6 Erythrasma is a mild skin infection which is identified as red, flat and without secretion spots. It is mainly observed in the skin of wrinkled and creased parts of the body, like the groin, armpit and fingers, usually as a result of Corynebacterium minutissimum infection. 7-9 The etiology of erythrasma is not entirely clear, but the involved microorganisms-especially in toe cleft infections-are supposed to be part of the normal body flora. 10 Azole antifungal drugs, such as clotrimazole and sertaconazole, usually take significant steps towards the treatment of erythrasma. 11,12 Erythromycin and tetracycline are other acknowledged alternative treatments. 8,13 Regarding the progressive quiddity of skin diseases like erythrasma, choosing the right treatment strategy can lead to lower costs for the health system and faster resolution for the patients. 14 On the other hand, eradicating infectious skin diseases from a community is only possible under the circumstances of rapid and firm therapeutic confrontation. 15 Concerning the full range of treatment options, there is no general agreement on the treatment protocol of erythrasma. 16 Therefore, this study was conducted to discuss and compare the effectiveness of clotrimazole and sertaconazole as the available drug choices in the treatment of erythrasma. Methods Study design and population In this double-blinded randomized controlled trial, 40 patients among the patients referred to the dermatology

show abstract

Dermatology Skills for Primary Care

Cited by 5 publications

References 0 publications

Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept study

Development and initial validation of the Localized Scleroderma Skin Damage Index and Physician Global Assessment of disease Damage: a proof-of-concept study

Nodular Melanoma Mimicking Keratoacanthoma : Lessons to Learn = ورم ميلانيني عقدي يحاكي ورم شائكي متقرن : دروس للتعل

Treatment of erythrasma: A double-blinded randomized controlled trial on the clinical application of clotrimazole and sertaconazole

Contact Info

Product

Resources

About